Holen Sie sich die Stockscreener-App
1.76
6.02%
0.10
Handel nachbörslich:
1.75
-0.01
-0.57%
Schlusskurs vom Vortag:
$1.66
Offen:
$1.66
24-Stunden-Volumen:
2.07M
Relative Volume:
1.02
Marktkapitalisierung:
$122.47M
Einnahmen:
$151.64M
Nettoeinkommen (Verlust:
$-37.23M
KGV:
-3.2211
EPS:
-0.5464
Netto-Cashflow:
$-13.58M
1W Leistung:
+24.82%
1M Leistung:
+41.94%
6M Leistung:
-14.98%
1J Leistung:
-50.28%
1-Tages-Spanne:
$1.535
$1.825
1-Wochen-Bereich:
$1.415
$1.825
52-Wochen-Spanne:
$0.80
$4.8495
Neuronetics Inc Stock (STIM) Company Profile
Firmenname
Neuronetics Inc
Sektor
Branche
Telefon
877-600-7555
Adresse
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.76 | 122.47M | 151.64M | -37.23M | -13.58M | -0.5464 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2018-07-24 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
What Does Jorey Chernett's Recent Buying Spree Signal for Neuronetics (STIM) - Kavout | AI
Neuronetics to Participate in a Panel Discussion at B. Riley Securities Mind, Muscle and Vision Summit on July 16, 2026 - marketscreener.com
Neuronetics to Participate at B. Riley Securities’ Mind, Muscle & Vision Summit - Quiver Quantitative
Neuronetics joins neuropsychiatry panel at B. Riley investor summit - Stock Titan
Neuronetics stock leans on its core therapy platform. - ad-hoc-news.de
STIM News | NEURONETICS INC (NASDAQ:STIM) - ChartMill
Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 2000 Dynamic Index - marketscreener.com
Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 3000E Index - marketscreener.com
Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 2500 Index - marketscreener.com
Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 2000 Index - marketscreener.com
Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Neuronetics, Inc.(NasdaqGM: STIM) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Neuronetics, Inc. Actuals & Estimates (NASDAQ:STIM) - TradingView
Neuronetics Inc (STIM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to book forward of Neuronetics, Inc. – NASDAQ:STIM - TradingView
Price to earnings forward of Neuronetics, Inc. – NASDAQ:STIM - TradingView
Enterprise value to EBITDA forward of Neuronetics, Inc. – NASDAQ:STIM - TradingView
Price to sales forward of Neuronetics, Inc. – NASDAQ:STIM - TradingView
STIM Forecast — Price Target — Prediction for 2027 - TradingView
A2JPMY Forecast — Price Target — Prediction for 2027 - TradingView
Neuronetics Inc (STIM) Institutional Confidence - TradingKey
Neuronetics, Inc. (STIM) Files 8-K Report: Company Details, Stock Info, and Compliance Data for June 2026 - Minichart
Form 8K Neuronetics Inc For: 23 June By Investing.com - Investing.com Nigeria
Cory Anderson named EVP, GM of Greenbrook at Neuronetics (NASDAQ: STIM) - Stock Titan
Neuronetics | 8-K: Current report - Moomoo
Neuronetics Inc (STIM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Neuronetics Inc (STIM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Neuronetics Inc (STIM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Neuronetics Inc (STIM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Neuronetics Inc (STIM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Neuronetics Inc (STIM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Neuronetics Inc (STIM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Neuronetics (NASDAQ: STIM) director reallocates 42,500 shares to Madryn funds - Stock Titan
Madryn funds (NASDAQ: STIM) reallocate 72,500 Neuronetics RSU shares - Stock Titan
Neuronetics Names Sales Chief, Grants Equity Incentive - MyChesCo
STIM (NASDAQ) affiliate files to sell 42,164 vested shares via Fidelity - Stock Titan
STIM Technical Analysis | Trend, Signals & Chart Patterns | NEURONETICS INC (NASDAQ:STIM) - ChartMill
Neuronetics names Robert Greene as senior VP, sales - Medical Buyer
Neuronetics largest shareholder pushes for strategic review - Investing.com
Neuronetics Appoints Robert Greene as Senior Vice President Sales - The Globe and Mail
New Neuronetics sales chief gets 200,000-share stock grant - Stock Titan
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026 - The Manila Times
New TMS data on teen and adult depression at CTMSS 2026 - Stock Titan
Neuronetics, Inc. (STIM) Submits Form 8-K Reporting Shareholder Vote Results – Key Filing Details and Company Information - Minichart
STIM Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Operational DisciplineNegative Surprise Momentum - dars.gov.et
Neuronetics Inc. (STIM) Holds Steady at $1.54 as Support and Resistance Define Trading RangeBreak of Structure - dars.gov.et
Neuronetics (STIM) director Megan Rosengarten granted 30,000 RSUs, now holds 170,890 shares - Stock Titan
Director at Neuronetics (STIM) receives 30,000-share RSU grant - Stock Titan
Neuronetics (STIM) director awarded 30,000 RSUs vesting by 2027 - Stock Titan
Neuronetics (STIM) director Sheryl Conley awarded 30,000 RSUs in stock grant - Stock Titan
Neuronetics (STIM) director granted 36,250 RSUs, holdings rise to 625,017 shares - Stock Titan
Finanzdaten der Neuronetics Inc-Aktie (STIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):